83% of participants on tecovirimat achieved clinical resolution, compared to 84% on placebo, which was not significantly different. Pain reduction was similar in both groups, with tecovirimat ...

Please provide your email address to receive an email when new articles are posted on . The NIH stopped recruiting for trials of tecovirimat against mpox after the drug was deemed not ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an international clinical ...

Scientists warn monkeypox could become a serious global threat as it shows signs of sustained human-to-human transmission.

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an international ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an international clinical ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an international ...

“Today’s announcement of a special cash dividend reflects the strength of our balance sheet and continued confidence in the future of our business,” said Diem Nguyen, Chief Executive Officer. “As we ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an international ...